Evidence map›Paper›PMID 40153444›Full record

ArticlePLoS pathogens2025

Dynamics of the adhesion complex of the human pathogens Mycoplasma pneumoniae and Mycoplasma genitalium.

David Vizarraga, Akihiro Kawamoto, Marina Marcos-Silva, Jesús Martín, Fumiaki Makino, Tomoko Miyata, Jorge Roel-Touris, Enrique Marcos, Oscar Q Pich, David Aparicio and 5 more

Abstract read
In one paragraph

Article in PLoS pathogens, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. A multi-epitope vaccine targetingFrontiers in immunology · 2026
    Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

David VizarragaInstituto de Biología Molecular de Barcelona (IBMB-CSIC), Parc Científic de Barcelona, Barcelona, Spain.
Akihiro KawamotoInstitute for Protein Research, Osaka University, Suita, Osaka, Japan.
Marina Marcos-SilvaDepartament de Bioquímica i de Biologia Molecular and Institut de Biotecnologia i Biomedicina, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Spain.
Jesús MartínInstituto de Biología Molecular de Barcelona (IBMB-CSIC), Parc Científic de Barcelona, Barcelona, Spain.
Fumiaki MakinoGraduate School of Frontier Biosciences, Osaka University, Suita, Osaka, Japan.
Tomoko MiyataGraduate School of Frontier Biosciences, Osaka University, Suita, Osaka, Japan.
Jorge Roel-TourisInstituto de Biología Molecular de Barcelona (IBMB-CSIC), Parc Científic de Barcelona, Barcelona, Spain.
Enrique MarcosInstituto de Biología Molecular de Barcelona (IBMB-CSIC), Parc Científic de Barcelona, Barcelona, Spain.
Oscar Q PichLaboratori de Recerca en Microbiologia i Malalties Infeccioses, Hospital Universitari Parc Taulí, Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA) and Institut de Biotecnologia i Biomedicina, Universitat Autònoma de Barcelona, Sabadell, Spain.
David AparicioInstituto de Biología Molecular de Barcelona (IBMB-CSIC), Parc Científic de Barcelona, Barcelona, Spain.
Ignacio FitaInstituto de Biología Molecular de Barcelona (IBMB-CSIC), Parc Científic de Barcelona, Barcelona, Spain.
Makoto MiyataGraduate School of Science, Osaka Metropolitan University, Osaka, Japan.
Jaume PiñolDepartament de Bioquímica i de Biologia Molecular and Institut de Biotecnologia i Biomedicina, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Spain.ORCID 0000-0002-9055-8934
Keiichi NambaGraduate School of Frontier Biosciences, Osaka University, Suita, Osaka, Japan.
Tsuyoshi KenriDepartment of Bacteriology II, National Institute of Infectious Diseases, Musashimurayama, Tokyo, Japan.ORCID 0000-0002-3198-4263

Funding

Research Support Project for Life Science and Drug DiscoverySpanish Ministry of Science and Innovation
6 · The paper itself

Abstract

Mycoplasma pneumoniae and Mycoplasma genitalium are bacterial wall-less human pathogens and the causative agents of respiratory and reproductive tract infections. Infectivity, gliding motility and adhesion of these mycoplasmas to host cells are mediated by orthologous adhesin proteins forming a transmembrane adhesion complex that binds to sialylated oligosaccharides human cell ligands. Here we report the cryo-EM structure of M. pneumoniae P1 adhesin bound to the Fab fragment of monoclonal antibody P1/MCA4, which stops gliding and induces detachment of motile cells. The epitope of P1/MCA4 involves residues only from the small C-domain of P1. This epitope is accessible to antibodies only in the "closed conformation" of the adhesion complex and is not accessible in the "open" conformation, when the adhesion complex is ready for attachment to sialylated oligosaccharides. Polyclonal antibodies generated against the large N-domain of P1 or against the whole ectodomain of P40/P90 have little or no effects on adhesion or motility. Moreover, mutations in the highly conserved Engelman motifs found in the transmembrane helix of M. genitalium P110 adhesin also alter adhesion and motility. These results show that antibodies directed to the C-domain of P1 hinder the large conformational rearrangements in this domain required to alternate between the "open" and "closed" conformations of the adhesion complex. Since transition between both conformations is essential to complete the attachment/detachment cycle of the adhesion complex, interfering with the gliding of mycoplasma cells and providing a new potential target to confront M. pneumoniae and M. genitalium infections.

Indexed as

Adhesins, BacterialBacterial AdhesionMycoplasma genitaliumMycoplasma InfectionsMycoplasma pneumoniaeCryoelectron MicroscopyHumansAdhesins, Bacterial

Identifiers

PMID40153444
PMCPMC11984735

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.